The psychedelic therapy landscape is advancing swiftly, blending ancient traditions with cutting-edge biotech to tackle mental health and addiction challenges. Luxembourg, a key EU hub, is witnessing increased interest in substances like ibogaine HCL and psilocybin for innovative wellness approaches. These compounds show promise for addiction, depression, PTSD, and comorbid issues such as ADHD and […]